Lorenzo Marcon
Overview
Explore the profile of Lorenzo Marcon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
47
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Monaco C, Cespon-Fernandez M, Pannone L, Del Monte A, Della Rocca D, Gauthey A, et al.
JACC Clin Electrophysiol
. 2025 Mar;
PMID: 40088219
Background: Brugada syndrome (BrS) continues to pose clinical challenges, despite 3 decades of dedicated research and therapeutic advancements. The pivotal role of implantable cardioverter-defibrillator (ICD) therapy in safeguarding high-risk BrS...
2.
Cespon-Fernandez M, Della Rocca D, Magnocavallo M, Betancur A, Lombardo I, Pannone L, et al.
J Interv Card Electrophysiol
. 2025 Mar;
PMID: 40038209
Background: Patients undergoing atrial fibrillation (AF) catheter ablation may require redo procedures involving pulmonary vein (PV) re-isolation and/or ablation of extra-PV sites. Pulsed field ablation (PFA) offers a highly selective...
3.
Marcon L, Della Rocca D, Vetta G, Nakasone K, Sorgente A, de Asmundis C, et al.
J Cardiovasc Electrophysiol
. 2025 Feb;
PMID: 39980085
Introduction: The extensive use of pulsed field ablation (PFA) in clinical settings has unveiled new evidence suggesting potential involvement in red blood cell structural impairment resulting in hemolysis and potential...
4.
Bergonti M, Krisai P, Ascione C, Pambrun T, Della Rocca D, Compagnucci P, et al.
JACC Clin Electrophysiol
. 2025 Feb;
PMID: 39895449
Background: Catheter ablation of atrial fibrillation has been proven beneficial in patients with heart failure and reduced ejection fraction (HFrEF). On top of pulmonary vein isolation (PVI), additional ablation strategies...
5.
Nakasone K, Della Rocca D, Magnocavallo M, Betancur A, Vetta G, Pannone L, et al.
Heart Rhythm
. 2025 Jan;
PMID: 39864479
Background: Catheter ablation is an effective treatment of atrial fibrillation. Pulsed field ablation (PFA) has emerged as a novel energy modality that relies on high-voltage electric fields to achieve cardiac...
6.
Vetta G, Della Rocca D, Sarkozy A, Mene R, Pannone L, Almorad A, et al.
Heart Rhythm
. 2024 Dec;
PMID: 39694305
Background: A novel focal lattice-tip catheter allowing the delivery of either pulsed field (PF) or radiofrequency (RF) energy has recently received regulatory approval. The technology features a proprietary 3-dimensional electroanatomic...
7.
Vetta G, Della Rocca D, Parlavecchio A, Magnocavallo M, Sorgente A, Pannone L, et al.
Europace
. 2024 Nov;
26(12).
PMID: 39579376
Aims: Pulsed field ablation (PFA) is an innovative technology recently adopted for the treatment of atrial fibrillation (AF). Preclinical and clinical studies have reported a remarkable safety profile, as a...
8.
Scacciavillani R, Della Rocca D, Nair D, Magnocavallo M, Glowniak A, Mohanty S, et al.
JACC Clin Electrophysiol
. 2024 Nov;
11(1):98-106.
PMID: 39570269
Background: Pulsed-field ablation (PFA) is a novel ablation energy source, which leads to selective and irreversible electroporation of cardiomyocytes with no collateral damage to adjacent tissues. The presence of mechanical...
9.
Vetta G, Parlavecchio A, Wright J, Magnocavallo M, Marcon L, Doundoulakis I, et al.
J Interv Card Electrophysiol
. 2024 Oct;
PMID: 39448460
Introduction: Ultrasound-guided (Echo-AVP) and Fluoroscopy-guided Axillary Vein Puncture (Fluoro-AVP) are both acknowledged as safe and effective techniques for transvenous implantation of leads for cardiac implantable electronic devices (CIEDs). Nonetheless, it...
10.
Della Rocca D, Sorgente A, Pannone L, Cespon-Fernandez M, Vetta G, Almorad A, et al.
Europace
. 2024 Oct;
26(10).
PMID: 39351961
Aims: Rhythm control of non-paroxysmal atrial fibrillation (AF) is significantly more challenging, as a result of arrhythmia perpetuation promoting atrial substrate changes and AF maintenance. We describe a tailored ablation...